Syapse Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 125

Employees

  • Latest Deal Type
  • M&A

Syapse General Information

Description

Developer of insights and data-sharing network designed to deliver precision cancer care. The company's platform integrates previously fragmented clinical, molecular, treatment and health outcomes data and delivers it to physicians at the point of care, enabling oncologists, healthcare systems, life sciences companies, and regulators to deliver personalized care with all the available insights.

Contact Information

Website
www.syapse.com
Formerly Known As
BDLicense
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 303 2nd Street, Sixth Floor
  • Suite 650
  • San Francisco, CA 94107
  • United States
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Media and Information Services (B2B)
Acquirer
N-Power Medicine
Vertical(s)
SaaS, TMT, HealthTech, Oncology
Corporate Office
  • 303 2nd Street, Sixth Floor
  • Suite 650
  • San Francisco, CA 94107
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Syapse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Merger/Acquisition 20-Dec-2024 Completed Generating Revenue
12. Later Stage VC 28-Jul-2022 Completed Generating Revenue
11. Secondary Transaction - Private 01-May-2022 Completed Generating Revenue
10. Secondary Transaction - Private Completed Generating Revenue
9. Later Stage VC (Series G) 02-Feb-2021 Completed Generating Revenue
8. Later Stage VC (Series F) 28-May-2020 Completed Generating Revenue
7. Debt - PPP 27-Apr-2020 Completed Generating Revenue
6. Later Stage VC (Series E) 06-May-2019 Completed Generating Revenue
5. Later Stage VC (Series D) 14-Nov-2017 $30M $68M Completed Generating Revenue
4. Later Stage VC (Series C) 12-Jan-2016 $25M $38M Completed Generating Revenue
To view Syapse’s complete valuation and funding history, request access »

Syapse Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series F
Series E
Series D
Series C
Series B 13,636,363 $0.000100 $0.06 $0.71 $0.71 1x $0.71 6.63%
Series A 7,923,661 $0.000100 $0.04 $0.48 $0.48 1x $0.48 3.85%
To view Syapse’s complete cap table history, request access »

Syapse Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of insights and data-sharing network designed to deliver precision cancer care. The company's platform integra
Enterprise Systems (Healthcare)
San Francisco, CA
125 As of 2023

New York, NY
 

Fort Myers, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Syapse Competitors (17)

One of Syapse’s 17 competitors is Aetion, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aetion Venture Capital-Backed New York, NY
Trapelo Health Formerly VC-backed Fort Myers, FL
InterpretOmics Formerly VC-backed Bangalore, India
Jana Analysis Corporation Chennai, India
NantHealth Formerly VC-backed Morrisville, NC
You’re viewing 5 of 17 competitors. Get the full list »

Syapse Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Syapse Former Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ally Bridge Group PE/Buyout Minority
Amgen Ventures Corporate Venture Capital Minority
Ascension Ventures Corporate Venture Capital Minority
CHV Capital Venture Capital Minority
Emerson Street Partners Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Syapse FAQs

  • When was Syapse founded?

    Syapse was founded in 2008.

  • Where is Syapse headquartered?

    Syapse is headquartered in San Francisco, CA.

  • What is the size of Syapse?

    Syapse has 125 total employees.

  • What industry is Syapse in?

    Syapse’s primary industry is Enterprise Systems (Healthcare).

  • Is Syapse a private or public company?

    Syapse is a Private company.

  • What is Syapse’s current revenue?

    The current revenue for Syapse is .

  • How much funding has Syapse raised over time?

    Syapse has raised $227M.

  • Who are Syapse’s investors?

    Ally Bridge Group, Amgen Ventures, Ascension Ventures, CHV Capital, and Emerson Street Partners are 5 of 18 investors who have invested in Syapse.

  • Who are Syapse’s competitors?

    Aetion, Trapelo Health, InterpretOmics, Jana Analysis, and NantHealth are some of the 17 competitors of Syapse.

  • When was Syapse acquired?

    Syapse was acquired on 20-Dec-2024.

  • Who acquired Syapse?

    Syapse was acquired by N-Power Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »